# SOLLUS THERAPEUTICS, INC.: Enhancing antigen sensitivity of BCMA CAR T cells for durable clinical responses inmultiple myeloma

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | SOLLUS THERAPEUTICS, INC. |
| Location | CHAPEL HILL, NC |
| Project | Enhancing antigen sensitivity of BCMA CAR T cells for durable clinical responses inmultiple myeloma |
| Project number | 1R41CA310458-01A1 |
| Mechanism | R41 |
| Institute | National Cancer Institute |
| Award | $373,452 |
| Awarded | 2026-09-07 |
| Project period | 2026-09-07 to 2027-08-31 |
| UEI | L6W7MCAYEBE3 |

## Why this score
- Award of $373,452.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11407469). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.